The MDT platform for thoracic oncology.
Every case, from referral to follow-up, as one list of decisions and actions — staged on IASLC 9th edition, operative risk in natural frequencies, guideline options with the evidence beside them, and the meeting minuted as it runs.
Aligned with IASLC 9th · ESTS · ERS · NICE · ESMO. Built for NHS lung cancer MDTs.
Four decisions, one pathway.
- Staging — cTNM and pTNM on the IASLC 9th edition, with stage migration shown explicitly and every descriptor traceable.
- Operative risk — predicted morbidity and mortality in natural frequencies (Eurolung, ThRCRI, ppoFEV₁/DLCO) — never a single false-precision number.
- Treatment planning — guideline-aligned options per stage with the pivotal evidence (NICE, ESMO, CheckMate 816, KEYNOTE-671) linked beside the recommendation.
- MDT workflow — one board from referral to follow-up; outcomes, actions and owners captured as the meeting runs, ready to audit.
Built for information governance.
Role-based access, a full exportable audit trail, a clinical safety hazard log kept with the code, and a readiness gate that holds the service back from real patients until every governance item is signed off.
Every output traces to a source.
Clinical algorithms drawn from the authoritative sources in thoracic oncology: IASLC 9th edition, ESTS, ERS, NICE and ESMO, with Eurolung and ThRCRI risk models. Built by Mr Alessandro Maraschi, MD FRCS (Eng), Consultant Thoracic & Robotic Surgeon.